DONGGUAN, GUANGDONG PROVINCE, CHINA, January 13, 2026 /EINPresswire.com/ -- As demand for personalized products ...
Proprio, the surgical technology company pioneering real-time, AI-powered intraoperative guidance and data-driven surgical workflows, today announced the U.S. Food and Drug Administration (FDA) has ...
Seattle, WA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- ReelTime Media (OTCID:RLTR) today announced that its Reel Intelligence (“RI”) ...
Unlike traditional transplant approaches, the goal is not to permanently replace a failing liver, but to create a temporary, ...
EverythingLubbock.com on MSN
Low-level helicopter surveys to map geology, aquifers over parts of New Mexico and Texas
The above video shows the top local headlines for the morning of January 15, 2026. LUBBOCK, Texas — Low-level helicopter ...
Currently, Kyocera’s technology enables aerial images whose focal positions vary by wavelength. In the future, increasing the ...
In April, the US Food & Drug Administration (FDA) announced its decision to phase out animal testing requirements for ...
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .
Notable seed investment led by Primary Venture Partners supports Haiqu’s mission to reduce costs and resources needed for quantum computation Haiqu minimizes hardware shortcomings to get the best of ...
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
We came across a bullish thesis on Nova Ltd. on Asymmetric Edge’s Substack. In this article, we will summarize the bulls’ thesis on NVMI. Nova Ltd.’s share was trading at $403.62 as of January 12th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback